Use of von Willebrand factor promoter to transduce suicidal gene to human endothelial cells, HUVEC

Human Gene Therapy

Volumn 7, Issue 13, 1996, Pages 1483-1490

  Ozaki, Katsutoshi ^a,b   Yoshida, Teruhiko ^a   Ide, Hisamitsu ^a   Saito, Izumu ^c   Ikeda, Yasuo ^b   Sugimura, Takashi ^a   Terada, Masaaki ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; LUCIFERASE; PRODRUG; THYMIDINE KINASE; VON WILLEBRAND FACTOR;

ADENOVIRUS; ANGIOGENESIS; ARTICLE; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELL KILLING; CELL PROLIFERATION; ENDOTHELIUM CELL; EXON; EXPRESSION VECTOR; GENE; GENE THERAPY; GENETIC TRANSDUCTION; GROWTH INHIBITION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; PROMOTER REGION; RETROVIRUS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0029743162     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.13-1483     Document Type: Article

References (35)

1. AIRD, W.C., JAHROUDI, N., WEILER-GUETTLER, H., RAYBURN, H., and ROSENBERG, R.D. (1995). Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice. Proc. Natl. Acad. Sci. USA 92, 4567-4571.
2. AUSUBEL, F.M., BRENT, R., KINGSTON, R.E., MOORE, D.D., SEIDMAN, J.G., SMITH, J.A., and STRUHL, K., eds. (1987). Current Protocols in Molecular Biology. (John Wiley & Sons, Inc., New York).
3. BAHNAK, B.R., WU, Q.Y., COULOMBEL, L., ASSOULINE, Z., KERBIRIOU-NABIAS, D., PIETU, G., DROUET, L., CAEN, J.P., and MEYER, D. (1989). Expression of von Willebrand factor in porcine vessels: heterogeneity at the level of von Willebrand factor mRNA. J. Cell. Physiol. 138, 305-310.
4. BLOOD, C.H., and ZETTER, B.R. (1990). Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim. Biophys. Acta 1032, 89-118.
5. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
6. FERREIRA, V., ASSOULINE, Z., SCHWACHTGEN, J.-L., BAHNAK, B.R., MEYER, D., and KERBIRIOU-NABIAS, D. (1993). The role of the 5′-flanking region in the cell-specific transcription of the human von Willebrand factor gene. Biochem. J. 293, 641-648.
7. FIDLER, I.J., and ELLIS, L.M. (1994). The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79, 185-188.
8. FOLKMAN, J. (1989). What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82, 4-6.
9. FOLKMAN, J., and HOCHBERG, M. (1973). Self-regulation of growth in three dimensions. J. Exp. Med. 138, 745-753.
10. FOLKMAN, J., and SHING, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
11. GIMBRONE, M.A., LEAPMAN, S.B., COTRAN, R.S., and FOLKMAN, J. (1972). Tumor dormancy in vivo by prevention of neovascularization. J. Exp. Med. 136, 261-276.
12. GUMKOWSKI, F., KAMINSKA, G., KAMINSKI, M., MORRISSEY, L.W., and AUERBACH, R. (1987). Heterogeneity of mouse vascular endothelium. Blood Vessels 24, 11-23.
13. HORI, A., SASADA, R., MATSUTANI, E., NAITO, K., SAKURA, Y., FUJITA, T., and KOZAI, Y. (1991). Suppression of solid tumor growth by immunoneutralizing monoclonal antibody against human basic fibroblast growth factor. Cancer Res. 51, 6180-6184.
14. HOYER, L.W., DE LOS SANTOS, R.P., and HOYER, J.R. (1973). Antihemophilic factor antigen: localization in endothelial cells by immunofluorescence microscopy. J. Clin. Invest. 52, 2737-2744.
15. JAFFE, E.A., NACHMAN, R.L., BECKER, C.G., and MINICK, R. (1973). Culture of human endothelial cells derived from umbilical veins. J. Clin. Invest. 52, 2745-2756.
16. JAHROUDI, N., and LYNCH, D.C. (1994). Endothelial-Cell-Specific Regulation of von Willebrand Factor Gene Expression. Mol. Cell. Biol. 14, 999-1008.
17. KANEGAE, Y., LEE, G., SATO, Y., TANAKA, M., NAKAI, M., SAKAKI, T., SUGANO, S., and SAITO, I. (1995). Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase. Nucl. Acids Res. 23, 3816-3821.
18. KIM, K.J., LI, B., WINER, J., ARMANINI, M., GILLETT, N., PHILLIPS, H.S., and FERRARA, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 362, 841-844.
19. MACGREGOR, G.R., NOLAN, G.P., FIERING, S., ROEDERER, M., and HERZENBERG, L.A. (1991). Use of E. coli lacZ (β-galactosidase) as a reporter gene. In Method in Molecular Biology, vol. 7: Gene Transfer and Expression Protocols. E.J. Murray, ed. (The Humana Press, Clifton, NJ) pp. 217-235.
20. MANCUSO, D.J., TULEY, E.A., WESTFIELD, L.A., WORRALL, N.K., SHELTON-INLOES, B.B., SORACE, J.M., ALEVY, Y.G., and SADLER, J.E. (1989). Structure of the gene for human von Willebrand factor. J. Biol. Chem. 264, 19514-19527.
21. MILLAUER, B., SHAWVER, L.K., PLATE, K.H., RISAU, W., and ULLRICH, A. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-579.
22. MILLER, A.D., and ROSMAN, G.J. (1989). Improved retroviral vectors for gene transfer and expression. Biotechniques 7, 980-990.
23. MIYAKE, S., MAKIMURA, M., KANEGAE, Y., HARADA, S., SATO, Y., TAKAMORI, K., TOKUDA, C., and SAITO, I. (1996). Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93, 1320-1324.
24. MUKAI, K., ROSAI, J., and BURGDORF, W.H. (1980). Localization of factor VIII-related antigen in vascular endothelial cells using an immunoperoxidase method. Am. J. Surg. Pathol. 4, 273-276.
25. NAKAJIMA, K., IKENAKA, K., NAKAHIRA, K., MORITA, N., and MIKOSHIBA, K. (1993). An improved retroviral vector for assaying promoter activity. FEBS Lett. 315, 129-133.
26. NGUYEN, V.T., MORANGE, M., and BENSAUDE, O. (1988). Firefly luciferase luminescence assay using scintillation counters for quantitation in transfected mammalian cells. Anal. Biochem. 171, 404-408.
27. OLSON, K.A., FRENCH, T.C., VALLEE, B.L., and FETT, J.W. (1994). A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res. 54, 4576-4579.
28. OLSON, K.A., FETT, J.W., FRENCH, T.C., KEY, M.E., and VALLEE, B. (1995). Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA 92, 442-446.
29. O'REILLY, M.S., HOLMGREN, L., SHING, Y., CHEN, C., ROSENTHAL, R.A., MOSES, M., LANE, W.S., CAO, Y., SAGE, E.H., and FOLKMAN, J. (1994). Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328.
30. TAKEBE, Y., SEIKI, M., FUJISAWA, J., HOY, P., YOKOTA, K., ARAI, K., YOSHIDA, M., and ARAI, N. (1988). SRalpha promoter: an efficient and versatile mammalian cDNA expression system composed of the Simian Virus 40 early promoter and the R-U5 segment of Human T-cell leukemia virus type 1 long terminal repeat. Mol. Cell. Biol. 8, 466-472.
31. WEIDNER, N., SEMPLE, J.P., WELCH, W.R., and FOLKMAN, J. (1991). Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324, 1-8.
32. WEIDNER, N., FOLKMAN, J., POZZA, F., BEVILACQUA, P., ALLRED, E.N., MOORE, D.H., MELI, S., and GASPARINI, G. (1992). Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J. Natl. Cancer Inst. 84, 1875-1887.
33. WEIDNER, N., CARROLL, P.R., FLAX, J., BLUMENFELD, W., and FOLKMAN, J. (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol. 143, 401-409.
34. WU, Q.Y., DROUET, L., CARRIER, J.L., ROTHSCHILD, C., BERARD, M., ROUAULT, C., CAEN, J.P., and MEYER, D. (1987). Differential distribution of von Willebrand factor in endothelial cells: Comparison between normal pigs and pigs with von Willebrand disease. Arteriosclerosis 7, 47-54.
35. YAMAOKA, M., YAMAMOTO, T., MASAKI, T., IKEYAMA, S., SUDO, K., and FUJITA, T. (1993). Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl)fumagillol (TNP-470; AGM-1470). Cancer Res. 53, 4262-4267.